Free CME from PeerView


Endocrinology & Diabetes CME

Jaime Almandoz, MD, MBA, FTOS
Credits: 1.0 CME / NCPD / AAPA
PVI, PeerView Institute for Medical Education
Practicing What We Preach: Your Role as an Obesity Medicine Specialist, Inspiring Change, and Overcoming Negative Weight Biases to Prioritize the Management of Obesity as a Chronic Disease
Jaime Almandoz, MD, MBA, FTOS / Angela Fitch, MD, FACP, FOMA
May 30, 2023
Credits: 1.0 CME
Joslin Diabetes Center
A Call to Action for Primary Care Professionals: Your Role in Saving the Eyesight of Patients With Diabetes
Mark W. Stolar, MD
September 30, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?
Norman E. Lepor, MD, FACC, FAHA, FSCAI
September 29, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
Marcia S. Brose, MD, PhD, FASCO
September 26, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Getting Ahead of the Curve: Identifying and Managing Obesity in Primary Care
Domenica M. Rubino, MD
July 28, 2022
Credits: 1.5 CME
Joslin Diabetes Center
A Call to Action for Diabetes Specialists: Your Role in Saving the Eyesight of Patients With Diabetes
Richard Beaser, MD
July 12, 2022
Medical Learning Institute, Inc.
A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes
Rajiv Agarwal, MD, MS
May 13, 2022
PVI, PeerView Institute for Medical Education
Building Skills for Clinical Practice: Optimizing Insulin Management and Personalizing Diabetes Care With Faster-Acting Formulations and Newer Options in Delivery Technology
Lucia M. Novak, MSN, ANP-BC, BC-ADM
April 27, 2022
Medical Learning Institute, Inc.
Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity
Javier Morales, MD, FACP, FACE
April 08, 2022
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD
March 25, 2022
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Rohit Loomba, MD, MHSc
AGA Institute
Test Your Knowledge of What’s Now and What’s Next: Modification of Metabolic Risk Factors to Improve Liver-Related and Cardiovascular‐Related Outcomes in NASH
Rohit Loomba, MD, MHSc
February 10, 2022
Bradley S. Miller, MD, PhD
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 30, 2021
Penn State College of Medicine
Clinical Colloquia in Retinal Disease: Updating Evidence-Based, Patient-Centered Care for Diabetic Retinopathy
Carl Regillo, MD
November 22, 2021
Domenica M. Rubino, MD/Donna H. Ryan, MD, FTOS
Medical Learning Institute, Inc.
Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Domenica M. Rubino, MD /
November 09, 2021
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 07, 2021
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView